PCBL Chemical Limited — Others, 23-07-2025: Statement of deviation(s) or variation(s) under Reg. 32

PCBL Chemical Limited has confirmed that the proceeds from its preferential allotment of 1.6 crore convertible warrants have been utilized as originally planned, with no deviation for the quarter ended June 30, 2025. The company initially received 112 Cr, which was fully used by September 2024 for debt repayment, working capital, and general corporate purposes. The remaining 336 Cr, due upon warrant exercise, has not yet been received as no warrants were exercised during the reported quarter. This reassures shareholders that allocated funds are being managed transparently and as per disclosed objectives.